PAVmed Inc.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| Gross Margin | — | — | — | — |
| Operating Expenses | ||||
| Research & Development | $4.3M | $2.6M | $1.7M | $489.3K |
| SG&A Expense | $6.3M | $5.4M | $3.9M | $1.3M |
| Operating Income | $-10.6M | $-8.0M | $-5.7M | — |
| Operating Margin | — | — | — | — |
| Interest Expense | $2.4M | $724.7K | — | — |
| Pretax Income | $-18.2M | $-9.5M | $-5.7M | — |
| Income Tax Expense | — | — | — | — |
| Net Income | $-18.0M | $-9.5M | $-5.7M | $-1.8M |
| Net Margin | — | — | — | — |
| EPS (Basic) | $-0.81 | $-0.71 | $-0.44 | $-0.16 |
| EPS (Diluted) | $-0.81 | $-0.71 | $-0.44 | $-0.16 |
| Shares Outstanding (Basic) | 27.1M | 14.6M | — | — |
| Shares Outstanding (Diluted) | 27.1M | 14.6M | 13.0M | 11.3M |
| Dividends Per Share | — | — | — | — |